BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toiyama Y, Miki C, Inoue Y, Minobe S, Urano H, Kusunoki M. Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surg Today. 2010;40:46-53. [PMID: 20037839 DOI: 10.1007/s00595-009-4016-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Andersson B, Ansari D, Nordén M, Nilsson J, Andersson R. Surgical stress response after colorectal resection. Int Surg 2013;98:292-9. [PMID: 24229011 DOI: 10.9738/INTSURG-D-12-00009.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
2 Ahmad N, Ammar A, Storr SJ, Green AR, Rakha E, Ellis IO, Martin SG. IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients. Cancer Immunol Immunother 2018;67:537-49. [PMID: 29256156 DOI: 10.1007/s00262-017-2106-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
3 Zhao S, Wu D, Wu P, Wang Z, Huang J. Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLoS One. 2015;10:e0139598. [PMID: 26440936 DOI: 10.1371/journal.pone.0139598] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 8.5] [Reference Citation Analysis]
4 Chang CM, Lam HYP, Hsu HJ, Jiang SJ. Interleukin-10: A double-edged sword in breast cancer. Tzu Chi Med J 2021;33:203-11. [PMID: 34386356 DOI: 10.4103/tcmj.tcmj_162_20] [Reference Citation Analysis]
5 Cha H, Lee EJ, Seong J. Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy. World J Gastroenterol 2017;23:2077-85. [PMID: 28373775 DOI: 10.3748/wjg.v23.i11.2077] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
6 Sato T, Terai M, Tamura Y, Alexeev V, Mastrangelo MJ, Selvan SR. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res 2011;51:170-82. [PMID: 22139852 DOI: 10.1007/s12026-011-8262-6] [Cited by in Crossref: 156] [Cited by in F6Publishing: 129] [Article Influence: 17.3] [Reference Citation Analysis]